Menu Search
Equities

Tri Chemical Laboratories Inc

22E:DUS

Tri Chemical Laboratories Inc

Actions
  • Price (EUR)17.70
  • Today's Change-0.40 / -2.21%
  • Shares traded0.00
  • 1 Year change-9.69%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 18:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tri Chemical Laboratories Inc. is mainly engaged in development, manufacturing and sales of high-purity chemicals for semiconductor manufacturing. The main products for semiconductor and solar cells include chemical vapor deposition (CVD) material, dry etching material and diffusion material. The other business is engaged in design and sales of tanks for chemical transportation, entrusted synthesis of chemicals and entrusted test of chemicals, as well as in the provision of research and analyzing of chemical properties.

  • Revenue in JPY (TTM)13.60bn
  • Net income in JPY3.05bn
  • Incorporated1978
  • Employees256.00
  • Location
    Tri Chemical Laboratories Inc8154-217, UenoharaUENOHARA-SHI 409-0112JapanJPN
  • Phone+81 554636600
  • Fax+81 554636161
  • Websitehttp://www.trichemical.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.